Deaglan Joseph McHugh

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Chung‐Han Lee, Martin H. Voss, Maria I. Carlo et al. · Journal of Clinical Oncology · 2022 · 182 citations · Full text

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Samuel A. Funt, Michael Lattanzi, Karissa Whiting et al. · Journal of Clinical Oncology · 2022 · 93 citations · Full text

Tumour size as a prognostic factor in carcinoma of the cervix: assessment by transrectal ultrasound

B MAGEE, John Logue, R. Swindell et al. · British Journal of Radiology · 1991 · 35 citations

Medical Ultrasound, Tumoral Pathology, Cervical Cancer +14

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

Deaglan Joseph McHugh, Jay Chudow, Mia DeNunzio et al. · Clinical Genitourinary Cancer · 2020 · 33 citations · Full text

Urology, Medicine, Igf-1r Inhibitor Cixutumumab +7

Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Results of a phase 2 trial.

Chung‐Han Lee, Martin H. Voss, Maria I. Carlo et al. · Journal of Clinical Oncology · 2021 · 32 citations

Urology, Oncology, Genitourinary Cancer +15